bpc-157 sequence amino acid as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers 𧬠PEPTIDES 𧬠, How
Description
The GLP-1 activity increases insulin secretion, and adding exogenous insulin significantly raises hypoglycemia risk
Start with doses at the lower end of the dosing range as directed by physician
If you find a source selling BPC-157 for a fraction of the market rate, it's highly likely they are compromising on purification, using inferior raw materials, or simply not selling what they claim to be
No commercial antibody kits for BPC-157 are available, so cross-reactivity is negligible
Some individuals find morning injections preferable to minimize daytime nausea
Science 352(6292):1436-1443. [doi.org]
